COLL vs. TEVA
Compare and contrast key facts about Collegium Pharmaceutical, Inc. (COLL) and Teva Pharmaceutical Industries Limited (TEVA).
Performance
COLL vs. TEVA - Performance Comparison
Loading graphics...
COLL vs. TEVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
COLL Collegium Pharmaceutical, Inc. | -28.19% | 61.61% | -6.92% | 32.67% | 24.20% | -6.74% | -2.67% | 19.86% | -6.99% | 18.56% |
TEVA Teva Pharmaceutical Industries Limited | -3.08% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
Fundamentals
COLL:
$1.32B
TEVA:
$35.48B
COLL:
$1.60
TEVA:
$1.21
COLL:
20.84
TEVA:
25.03
COLL:
0.50
TEVA:
0.19
COLL:
1.68
TEVA:
2.04
COLL:
4.38
TEVA:
4.48
COLL:
$780.57M
TEVA:
$17.26B
COLL:
$463.26M
TEVA:
$8.94B
COLL:
$599.85M
TEVA:
$3.80B
Returns By Period
In the year-to-date period, COLL achieves a -28.19% return, which is significantly lower than TEVA's -3.08% return. Over the past 10 years, COLL has outperformed TEVA with an annualized return of 5.66%, while TEVA has yielded a comparatively lower -5.21% annualized return.
COLL
- 1D
- 0.54%
- 1M
- -20.07%
- YTD
- -28.19%
- 6M
- -5.46%
- 1Y
- 13.13%
- 3Y*
- 11.49%
- 5Y*
- 7.30%
- 10Y*
- 5.66%
TEVA
- 1D
- 0.43%
- 1M
- -10.42%
- YTD
- -3.08%
- 6M
- 50.80%
- 1Y
- 97.84%
- 3Y*
- 50.64%
- 5Y*
- 21.38%
- 10Y*
- -5.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
COLL vs. TEVA — Risk / Return Rank
COLL
TEVA
COLL vs. TEVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| COLL | TEVA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.34 | 2.33 | -2.00 |
Sortino ratioReturn per unit of downside risk | 0.78 | 3.11 | -2.33 |
Omega ratioGain probability vs. loss probability | 1.09 | 1.42 | -0.33 |
Calmar ratioReturn relative to maximum drawdown | 0.32 | 4.44 | -4.12 |
Martin ratioReturn relative to average drawdown | 1.01 | 12.93 | -11.92 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| COLL | TEVA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.34 | 2.33 | -2.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | 0.50 | -0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.10 | -0.11 | +0.22 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | 0.31 | -0.14 |
Correlation
The correlation between COLL and TEVA is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
COLL vs. TEVA - Dividend Comparison
Neither COLL nor TEVA has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLL Collegium Pharmaceutical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Drawdowns
COLL vs. TEVA - Drawdown Comparison
The maximum COLL drawdown since its inception was -73.59%, smaller than the maximum TEVA drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for COLL and TEVA.
Loading graphics...
Drawdown Indicators
| COLL | TEVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.59% | -90.89% | +17.30% |
Max Drawdown (1Y)Largest decline over 1 year | -35.81% | -21.79% | -14.02% |
Max Drawdown (5Y)Largest decline over 5 years | -43.99% | -43.70% | -0.29% |
Max Drawdown (10Y)Largest decline over 10 years | -65.22% | -88.71% | +23.49% |
Current DrawdownCurrent decline from peak | -33.29% | -55.29% | +22.00% |
Average DrawdownAverage peak-to-trough decline | -31.16% | -31.90% | +0.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.28% | 7.49% | +3.79% |
Volatility
COLL vs. TEVA - Volatility Comparison
Collegium Pharmaceutical, Inc. (COLL) and Teva Pharmaceutical Industries Limited (TEVA) have volatilities of 11.41% and 11.82%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| COLL | TEVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.41% | 11.82% | -0.41% |
Volatility (6M)Calculated over the trailing 6-month period | 27.80% | 27.30% | +0.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.31% | 42.20% | -2.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.23% | 42.76% | -2.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.38% | 47.20% | +7.18% |
Financials
COLL vs. TEVA - Financials Comparison
This section allows you to compare key financial metrics between Collegium Pharmaceutical, Inc. and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
COLL vs. TEVA - Profitability Comparison
COLL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported a gross profit of 128.38M and revenue of 205.45M. Therefore, the gross margin over that period was 62.5%.
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 2.66B and revenue of 4.71B. Therefore, the gross margin over that period was 56.4%.
COLL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported an operating income of 59.22M and revenue of 205.45M, resulting in an operating margin of 28.8%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported an operating income of 1.27B and revenue of 4.71B, resulting in an operating margin of 26.9%.
COLL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported a net income of 16.96M and revenue of 205.45M, resulting in a net margin of 8.3%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported a net income of 480.00M and revenue of 4.71B, resulting in a net margin of 10.2%.